| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 731009 | 85967 | VILDAGLIPTINA STADA 50 MG COMPRIMIDOS EFG | VILDAGLIPTINA STADA 50 MG COMPRIMIDOS EFG, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85967/85967_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85967/85967_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2021-05-16 | 1 | 1 | 1 | 2021-05-18 | 2021-05-16 | 1 | 2022-07-20 | View Edit Delete | ||||||||||||
| 731010 | 85967 | VILDAGLIPTINA STADA 50 MG COMPRIMIDOS EFG | VILDAGLIPTINA STADA 50 MG COMPRIMIDOS EFG, 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85967/85967_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85967/85967_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2021-05-16 | 1 | 1 | 1 | 2021-05-18 | 2021-05-16 | 1 | 2022-07-20 | View Edit Delete | ||||||||||||
| 731014 | 85970 | METAMIZOL COMBIX 575 MG CAPSULAS DURAS EFG | METAMIZOL COMBIX 575 MG CAPSULAS DURAS EFG, 10 capsulas | 575 mg | 5 | 10 | 43 | 10 capsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85970/85970_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85970/85970_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2021-05-16 | 1 | 1 | 1 | 2021-05-18 | 2021-05-16 | 0 | 2022-10-17 | View Edit Delete | ||||||||||||
| 731015 | 85970 | METAMIZOL COMBIX 575 MG CAPSULAS DURAS EFG | METAMIZOL COMBIX 575 MG CAPSULAS DURAS EFG, 20 capsulas | 575 mg | 5 | 20 | 43 | 20 capsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85970/85970_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85970/85970_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2021-05-16 | 1 | 1 | 1 | 2021-05-18 | 2021-05-16 | 0 | 2022-10-17 | View Edit Delete | ||||||||||||
| 731011 | 85968 | DIAZEPAM NORMON 2,5 MG COMPRIMIDOS | DIAZEPAM NORMON 2,5 MG COMPRIMIDOS, 40 comprimidos | 2,5 mg | 5 | 40 | 10 | 40 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85968/85968_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85968/85968_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2021-05-16 | 1 | 1 | 1 | 2021-05-18 | 2021-05-16 | 1 | 2021-08-11 | Lista IV | View Edit Delete | |||||||||||
| 731012 | 85969 | DIAZEPAM NORMON 10 MG COMPRIMIDOS EFG | DIAZEPAM NORMON 10 MG COMPRIMIDOS EFG, 25 comprimidos | 10 mg | 5 | 25 | 10 | 25 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85969/85969_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85969/85969_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2021-05-16 | 1 | 1 | 1 | 2021-05-18 | 2021-05-16 | 1 | 2021-08-11 | Lista IV | View Edit Delete | |||||||||||
| 731013 | 85969 | DIAZEPAM NORMON 10 MG COMPRIMIDOS EFG | DIAZEPAM NORMON 10 MG COMPRIMIDOS EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85969/85969_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85969/85969_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2021-05-16 | 1 | 1 | 1 | 2021-05-18 | 2021-05-16 | 1 | 2021-08-11 | Lista IV | View Edit Delete | |||||||||||
| 726085 | 84240 | SORAFENIB TEVA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SORAFENIB TEVA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 112 comprimidos | 200 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84240/84240_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84240/84240_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2019-06-11 | 1 | 1 | 1 | 2021-05-16 | 2021-05-16 | 1 | 2021-06-11 | View Edit Delete | ||||||||||||
| 731000 | 85962 | LACOSAMIDA TARBIS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85962/85962_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85962/85962_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 731001 | 85963 | LACOSAMIDA TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 150 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85963/85963_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85963/85963_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 731002 | 85964 | LACOSAMIDA TARBIS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 200 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85964/85964_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85964/85964_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 731003 | 85965 | LACOSAMIDA TARBIS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 14 comprimidos | 50 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85965/85965_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85965/85965_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 730662 | 85874 | TEICOPLANINA HIKMA 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | TEICOPLANINA HIKMA 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION O SOLUCION ORAL EFG, 1 vial | 400 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85874/85874_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85874/85874_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | HIKMA ESPAÑA, S.L.U. | 2021-05-13 | 1 | 1 | 1 | 2021-05-13 | 2021-05-13 | 1 | 2023-02-09 | View Edit Delete | ||||||||||||
| 730789 | 1211535005 | PEMAZYRE 13,5 mg COMPRIMIDOS | PEMAZYRE 13,5 mg COMPRIMIDOS, 14 comprimidos | 13,5 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211535005/1211535005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211535005/1211535005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29470 | INCYTE BIOSCIENCES IBERIA S.L. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 0 | 2023-12-12 | View Edit Delete | ||||||||||||
| 730993 | 02218009IP | AXURA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | AXURA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 112 comprimidos | 10 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02218009IP/02218009IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02218009IP/02218009IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1839 | ELAM PHARMA LABS S.L. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 1 | 2023-01-19 | View Edit Delete | ||||||||||||
| 730992 | 08484009IP | ICANDRA 50 mg/1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ICANDRA 50 mg/1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 50 mg/1.000 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08484009IP/08484009IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08484009IP/08484009IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ECOFAR PRODUCTOS S.L. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 0 | 2021-09-01 | View Edit Delete | ||||||||||||
| 730969 | 01199001IP | TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION | TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION 1 frasco de 2,5 ml | 40 microgramos/ml | 6 | 2,5 | 26 | 1 frasco de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01199001IP/01199001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01199001IP/01199001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | MELYFARMA S.L. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 1 | 2021-06-29 | View Edit Delete | ||||||||||||
| 730996 | 1171220001IP1 | TECENTRIQ 1.200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | TECENTRIQ 1200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 1.200 mg inyectable 20 ml | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171220001IP1/1171220001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171220001IP1/1171220001IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | MELYFARMA S.L. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 730836 | 1211536001 | THIOTEPA RIEMSER 15 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | THIOTEPA RIEMSER 15 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 15 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211536001/1211536001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211536001/1211536001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 0 | 2022-01-14 | View Edit Delete | ||||||||||||
| 730837 | 1211536002 | THIOTEPA RIEMSER 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | THIOTEPA RIEMSER 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211536002/1211536002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211536002/1211536002_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 0 | 2022-01-14 | View Edit Delete |
Page 183 of 1036, showing 20 records out of 20704 total, starting on record 3641, ending on 3660